AL
CYTK icon

Airain Ltd’s Cytokinetics CYTK Stock Holding History

Airain Ltd’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$289K Sell
23,884
-17,864
-43% -$248K 0.01% 670
2017
Q1 		$536K Buy
41,748
+19,948
+92% +$233K 0.03% 473
2016
Q4 		$265K Buy
+21,800
New +$231K 0.02% 529
2015
Q3 		– Sell
-11,888
Closed -$80K – 887
2015
Q2 		$80K Sell
11,888
-4,024
-25% -$26.4K ﹤0.01% 827
2015
Q1 		$108K Buy
+15,912
New +$119K 0.01% 758
2014
Q2 		– Sell
-16,615
Closed -$158K – 793
2014
Q1 		$158K Buy
+16,615
New +$150K 0.03% 619
2013
Q3 		– Sell
-12,249
Closed -$142K – 508
2013
Q2 		$142K Buy
+12,249
New +$96.5K 0.02% 499

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Airain Ltd's CYTK Position: Q2 2017 in Review

Airain Ltd reduced its Cytokinetics (CYTK) stake by 43% in Q2 2017, selling an estimated $248K and leaving 23,884 shares worth $289K. The position accounts for 0.01% of the portfolio, ranked #670.

Airain Ltd first reported a position in CYTK in Q2 2013 and has held it in 7 quarters since. The position peaked at $536K in Q1 2017. 136 funds tracked by Wall St. Rank hold CYTK as of Q2 2017.

  • Airain Ltd held 23,884 shares of Cytokinetics worth $289K as of Q2 2017.
  • Airain Ltd sold 17,864 Cytokinetics shares in Q2 2017, an estimated $248K.
  • Cytokinetics made up 0.01% of Airain Ltd's portfolio in Q2 2017, its #670 holding.
  • Airain Ltd first reported a position in Cytokinetics in Q2 2013 and has held it in 7 quarters since.
  • Airain Ltd's Cytokinetics position peaked at $536K in Q1 2017.
  • 136 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.